Cleared Traditional

K162384 - TrailBlazer Angled Support Catheter

K162384 is an FDA 510(k) clearance for TrailBlazer Angled Support Catheter, manufactured by Medtronic Vascular, Inc.(Formerly Ev3 Inc.). The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K162384 · Medtronic Vascular, Inc.(Formerly Ev3 Inc.) · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2016
Decision
28d
Days
Class 2
Risk

K162384 is an FDA 510(k) clearance for the TrailBlazer Angled Support Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Medtronic Vascular, Inc.(Formerly Ev3 Inc.) (Plymouth, US). The FDA issued a Cleared decision on September 22, 2016 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medtronic Vascular, Inc.(Formerly Ev3 Inc.) devices

FDA 510(k) Submission Details - K162384

510(k) Number K162384 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 25, 2016
Decision Date September 22, 2016
Days to Decision 28 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 780
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K162384.
Boosting Catheter
K160561 · Qxmedical, LLC · Nov 2016
R2P SlenGuide
K161546 · Ashitaka Factory of Terumo Corporation · Oct 2016
Navien Intracranial Support Catheter
K161152 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Oct 2016
Surefire Guiding Catheter
K162359 · Surefire Medical, Inc. · Sep 2016
Super Distal Access (SDA)
K161262 · Inneuroco, Inc. · Sep 2016
TorqVue Low Profile Delivery Catheter
K162228 · Aga Medical Corporation (Wholly Owned by St.Jude Medical Cor · Sep 2016